Debt-to-Equity Ratio in Pharmaceuticals & Healthcare
How to interpret and apply debt-to-equity ratio specifically when analyzing pharmaceuticals & healthcare stocks in India.
Quick Recap: What is Debt-to-Equity Ratio?
The D/E ratio shows how much debt a company uses relative to its equity — measuring financial leverage and risk of over-borrowing.
Debt-to-Equity = Total Debt ÷ Shareholders' Equity
How Debt-to-Equity Ratio Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical D/E0.2-0.8x
General benchmark: Below 0.5 is conservative, 0.5-1.0 moderate, above 2.0 is aggressive. Banks excluded.
Example Pharmaceuticals & Healthcare Companies to Analyze
Use the Equiscale Screener → to filter pharmaceuticals & healthcare stocks by debt-to-equity ratio and other metrics.
Key Takeaways
- Debt-to-Equity Ratio in pharmaceuticals & healthcare should be compared against sector peers, not the market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Always cross-check with other metrics. No single ratio tells the full story.